Landscape Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Landscape Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-9,500	Closed	-$916K	–	751
2018 Q4	$916K	Hold	9,500	–	–	0.08%	273
2018 Q3	$1.16M	Hold	9,500	–	–	0.09%	219
2018 Q2	$1.04M	Hold	9,500	–	–	0.09%	183
2018 Q1	$1.01M	Buy	9,500 +5,000	+111%	+$554K	0.07%	220
2017 Q4	$480K	Buy	+4,500	New	+$481K	0.04%	398
2016 Q1	–	Sell	-43,500	Closed	-$4.91M	–	686
2015 Q4	$4.91M	Sell	43,500 -22,500	-34%	-$2.44M	0.61%	15
2015 Q3	$6.67M	Buy	66,000 +6,000	+10%	+$720K	0.91%	17
2015 Q2	$7.38M	Buy	+60,000	New	+$7.18M	1.25%	7

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Landscape Capital Management's IBB Position: Q1 2019 in Review

Landscape Capital Management sold out of iShares Biotechnology ETF (IBB) in Q1 2019, closing a stake of 9,500 shares — an estimated $916K sold.

Landscape Capital Management first reported a position in IBB in Q2 2015 and held it in 8 quarters. The position peaked at $7.38M in Q2 2015. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

Landscape Capital Management reported no remaining iShares Biotechnology ETF position as of Q1 2019 after selling out during the quarter.
Landscape Capital Management sold 9,500 iShares Biotechnology ETF shares in Q1 2019, an estimated $916K.
Landscape Capital Management first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 8 quarters.
Landscape Capital Management's iShares Biotechnology ETF position peaked at $7.38M in Q2 2015.
670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on Landscape Capital Management's 13F filing for Q1 2019, filed 15 May 2019.